Exact Therapeutics AS Financial Flexibility Index
Exact Therapeutics AS financial flexibility index. Exact Therapeutics AS (EXTX) has a Financial Flexibility Index of -2.10x as of December 2024. Free cash flow of Nkr-79.04 Million (operating CF Nkr-80.55 Million minus capex Nkr1.51 Million) represents -2% of total liabilities (Nkr37.65 Million). Check EXTX asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Exact Therapeutics AS (2017–2024)
Financial flexibility index of Exact Therapeutics AS from 2017 to 2024. Historical Financial Flexibility Index trend for Exact Therapeutics AS across 8 annual periods. Explore Exact Therapeutics AS cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Exact Therapeutics AS Financial Flexibility Index by Year (2017–2024)
Exact Therapeutics AS financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for Exact Therapeutics AS. For the full cash flow conversion analysis, see EXTX cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.10x | Nkr-79.04 Million | Nkr-80.55 Million | Nkr37.65 Million | ▲ +17.4% |
| 2023 | -2.54x | Nkr-41.20 Million | Nkr-44.30 Million | Nkr16.22 Million | ▼ -31.6% |
| 2022 | -1.93x | Nkr-33.60 Million | Nkr-33.85 Million | Nkr17.40 Million | ▲ +57.1% |
| 2021 | -4.50x | Nkr-53.48 Million | Nkr-55.11 Million | Nkr11.89 Million | ▼ -116.1% |
| 2020 | -2.08x | Nkr-22.03 Million | Nkr-25.99 Million | Nkr10.58 Million | ▼ -85.7% |
| 2019 | -1.12x | Nkr-11.07 Million | Nkr-12.46 Million | Nkr9.87 Million | ▲ +37.5% |
| 2018 | -1.79x | Nkr-11.07 Million | Nkr-12.46 Million | Nkr6.17 Million | ▼ -89.2% |
| 2017 | -0.95x | Nkr-11.07 Million | Nkr-12.46 Million | Nkr11.68 Million | — |